Long-term allograft survival in the absence of continuous immunosuppression can be induced following a short treatment of nondepleting antibodies, such as those that target CD4 or CD154 (CD40 ligand). It is now established that this may involve dominant tolerance mechanisms that are maintained by CD4+ regulatory T cells present within the lymphoid tissue and the tolerated graft. The phenotype of these cells, their relationship to CD4+CD25+ T cells, and the mechanism of action are still controversial.Journal ArticleReviewSCOPUS: re.jinfo:eu-repo/semantics/publishe
International audienceA major challenge in transplantation medicine is controlling the very strong i...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
A short-treatment with nondepleting antibodies, such as those targeting CD4 or CD154 (CD40 ligand), ...
Short courses of antibody treatment aimed at blocking the coreceptors CD4 and CD8 and/or costimulato...
Solid organ transplantation is widely accepted as an effective treatment for end organ failure. Alth...
The past 15 years have seen a substantial increase in our knowledge of how short-term therapy with a...
Copyright © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimCostimulation blockade has been one of th...
To investigate the antigen specificity of regulatory T cells capable of preventing transplant reject...
International audienceOrgan transplantation is widely acknowledged as the best option for end stage ...
International audienceOrgan transplantation is widely acknowledged as the best option for end stage ...
Non-lytic antibodies to CD4 and certain other T cell adhesion receptors can guide the immune system ...
Non-lytic antibodies to CD4 and certain other T cell adhesion receptors can guide the immune system ...
Transplantation tolerance can be induced by a range of agents that block T cell/antigen-presenting c...
While the development of powerful immunosuppressive medications enabled the use of organ transplanta...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
A short-treatment with nondepleting antibodies, such as those targeting CD4 or CD154 (CD40 ligand), ...
Short courses of antibody treatment aimed at blocking the coreceptors CD4 and CD8 and/or costimulato...
Solid organ transplantation is widely accepted as an effective treatment for end organ failure. Alth...
The past 15 years have seen a substantial increase in our knowledge of how short-term therapy with a...
Copyright © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimCostimulation blockade has been one of th...
To investigate the antigen specificity of regulatory T cells capable of preventing transplant reject...
International audienceOrgan transplantation is widely acknowledged as the best option for end stage ...
International audienceOrgan transplantation is widely acknowledged as the best option for end stage ...
Non-lytic antibodies to CD4 and certain other T cell adhesion receptors can guide the immune system ...
Non-lytic antibodies to CD4 and certain other T cell adhesion receptors can guide the immune system ...
Transplantation tolerance can be induced by a range of agents that block T cell/antigen-presenting c...
While the development of powerful immunosuppressive medications enabled the use of organ transplanta...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
International audienceA major challenge in transplantation medicine is controlling the very strong i...
International audienceA major challenge in transplantation medicine is controlling the very strong i...